Rescentris and Amphora Research Systems Team Up to Deliver Electronic Lab Notebook Solution to Pharmaceutical Client
Rescentris Ltd. announced today the deployment of a complete electronic lab notebook and patent records solution for a pharmaceutical customer. This integrated product, which is now generally available, combines the Collaborative Electronic Research Framework(TM) (CERF-Notebook) from Rescentris with the PatentSafe(R) product of Amphora Research Systems to provide a turnkey solution for electronic lab notebooks and patent records management.
The system was designed to satisfy needs of multiple stakeholders in the pharmaceutical company, including the scientists, R&D Management, and patent lawyers. Rescentris CERF offers the biologists easy-to-use scientific content management in a full-featured electronic lab notebook in order to organize and share their research and also capture data and annotations in compliance with 21 CFR Part 11. Transparent to the scientists, completed experiments are then converted to archival PDF reports and transferred to Amphora’s industry-proven patent evidence system, PatentSafe(R), to create legally defendable records that may be signed electronically or printed on special security paper.
“The addition of PatentSafe(R) integration to CERF allows us to provide our clients the best of both worlds,” said Dr. Adel Mikhail, Rescentris CEO. “The advantages of an electronic laboratory notebook such as CERF include immediate access to search, retrieval, and collaboration of information. Our product uniquely enables our clients to actively capture Intellectual Property as it is created. The seamless integration with Amphora’s PatentSafe(R) system allows organizations to easily create robust evidence for patent protection, whether they require a paper record or are comfortable with a paperless system.”
The CERF-Notebook(TM) system is designed to allow rapid customization and integration with other systems. “Working with Rescentris has been a pleasure,” said Simon Coles, President and COO of Amphora Research Systems, developers of PatentSafe(R). “CERF is a powerful, flexible framework and the integration of CERF and PatentSafe(R) gives biologists a great place to work without compromising on Intellectual Property Protection.”
The pharmaceutical company that purchased the CERF-Notebook(TM) system with PatentSafe(R) integration could not be disclosed.
About Rescentris
Rescentris provides electronic laboratory notebook and collaborative scientific content management software solutions for life sciences R&D organizations. Its cross-platform product, the Collaborative Electronic Research Framework(TM) (CERF), is built on information standards and ontologies to integrate informatics, electronic record-keeping, and knowledge management. Rescentris focuses on delivering “IT to improve the ROI of R&D(TM)” – its solutions are designed to enhance productivity and decision making for scientists and R&D managers by capturing knowledge and intellectual property and disseminating it as unified and personalized views of enterprise discovery. See www.rescentris.com for more information.
About Amphora
Amphora Research Systems provides cost-effective alternatives to the bound paper lab notebook which are more appropriate for the computer age, yet still fulfill legal counsel’s requirement for evidence to support Patent claims in the event of dispute. Amphora’s solutions are in use by companies large and small and support a wide variety of scientific activity. For more information see http://www.amphora-research.com/
